Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

May 15, 2022; Volume 19,Issue 5

Editorial

  • You have access
    PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer
    Han Liang
    Cancer Biology & Medicine May 2022, 19 (5) 565-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0244

Perspective

  • You have access
    Therapeutic revolution for inoperable stage III non-small cell lung cancer in the immune era
    Jiakang Li, Jingyan Xu, Mingyi Yang and Qing Zhou
    Cancer Biology & Medicine May 2022, 19 (5) 569-572; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0254

Reviews

  • You have access
    Targeting the COP9 signalosome for cancer therapy
    Wenqi Du, Ruicheng Zhang, Bilal Muhammad and Dongsheng Pei
    Cancer Biology & Medicine May 2022, 19 (5) 573-590; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0605
  • You have access
    Advances in lung cancer screening and early detection
    Caichen Li, Huiting Wang, Yu Jiang, Wenhai Fu, Xiwen Liu, Ran Zhong, Bo Cheng, Feng Zhu, Yang Xiang, Jianxing He and Wenhua Liang
    Cancer Biology & Medicine May 2022, 19 (5) 591-608; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0690
  • You have access
    Immunology and immunotherapy in breast cancer
    Vladimir Semiglazov, Andrey Tseluiko, Asel Kudaybergenova, Anna Artemyeva, Petr Krivorotko and Roman Donskih
    Cancer Biology & Medicine May 2022, 19 (5) 609-618; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0597
  • You have access
    The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?
    Wen Liu, Xuejing Yan and Ruochuan Cheng
    Cancer Biology & Medicine May 2022, 19 (5) 619-634; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0058

Original Articles

  • You have access
    Akt isoforms differentially provide for chemoresistance in prostate cancer
    Bo Ma, Hanshuang Shao, Xia Jiang, Zhou Wang, Chuanyue (Cary) Wu, Diana Whaley and Alan Wells
    Cancer Biology & Medicine May 2022, 19 (5) 635-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0747
  • You have access
    JaponiconeA induces apoptosis of bortezomib-sensitive and -resistant myeloma cells in vitro and in vivo by targeting IKKβ
    Zilu Zhang, Chenjing Ye, Jia Liu, Wenbin Xu, Chao Wu, Qing Yu, Xiaoguang Xu, Xinyi Zeng, Huizi Jin, Yingli Wu and Hua Yan
    Cancer Biology & Medicine May 2022, 19 (5) 651-668; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0473
  • You have access
    Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/BRAF/TAK1/ERK/ETV4 signaling
    Panpan Ma, Xinxin Jin, Zhiwei Fan, Zhou Wang, Suhui Yue, Changyue Wu, Shiyin Chen, Yuanyuan Wu, Miaomiao Chen, Donghua Gu, Siliang Zhang, Renfang Mao and Yihui Fan
    Cancer Biology & Medicine May 2022, 19 (5) 669-684; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0137
  • You have access
    Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy
    Fan Kou, Lei Wu, Yan Guo, Bailu Zhang, Baihui Li, Ziqi Huang, Xiubao Ren and Lili Yang
    Cancer Biology & Medicine May 2022, 19 (5) 685-695; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0728
  • You have access
    Effects of population aging on the mortality burden of related cancers in urban and rural areas of China, 2004–2017: a population-based study
    Yali Chen, Cuihong Yang, Ning Li, Zixing Wang, Peng Wu, Jin Du and Jingmei Jiang
    Cancer Biology & Medicine May 2022, 19 (5) 696-706; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0538
  • You have access
    Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population
    Jianfei Yao, Yunhuan Zhen, Jing Fan, Yuan Gong, Yumeng Ye, Shaohua Guo, Hongyi Liu, Xiaoyun Li, Guosheng Li, Pan Yang, Xiaohui Wang, Danni Liu, Tanxiao Huang, Huiya Cao, Peisu Suo, Yuemin Li, Jingbo Yu and Lele Song
    Cancer Biology & Medicine May 2022, 19 (5) 707-732; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0190
  • You have access
    Improved diagnosis of thyroid cancer aided with deep learning applied to sonographic text reports: a retrospective, multi-cohort, diagnostic study
    Qiang Zhang, Sheng Zhang, Jianxin Li, Yi Pan, Jing Zhao, Yixing Feng, Yanhui Zhao, Xiaoqing Wang, Zhiming Zheng, Xiangming Yang, Lixia Liu, Chunxin Qin, Ke Zhao, Xiaonan Liu, Caixia Li, Liuyang Zhang, Chunrui Yang, Na Zhuo, Hong Zhang, Jie Liu, Jinglei Gao, Xiaoling Di, Fanbo Meng, Wei Ji, Meng Yang, Xiaojie Xin, Xi Wei, Rui Jin, Lun Zhang, Xudong Wang, Fengju Song, Xiangqian Zheng, Ming Gao, Kexin Chen and Xiangchun Li
    Cancer Biology & Medicine May 2022, 19 (5) 733-741; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0509
  • You have access
    Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis
    Junjie Li, Li Chen, Wei Tan, Fang Qi, Yang Zhang, Zhonghua Wang and Zhimin Shao
    Cancer Biology & Medicine May 2022, 19 (5) 742-754; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0529
  • You have access
    The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study
    Litong Yao, Zhiyuan Pang, Mozhi Wang, Mengshen Wang, Xiangyu Sun, Mingke Cui, Yanfu Zheng, Xinyan Li, Haoran Dong, Qiang Zhang and Yingying Xu
    Cancer Biology & Medicine May 2022, 19 (5) 755-767; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0800
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 19 (5)
Cancer Biology & Medicine
Vol. 19, Issue 5
15 May 2022
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Perspective
  • Reviews
  • Original Articles

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire